Aktuelle Verpflichtungen Veränderung Datum
Bausch Health Companies USD 4.53B 350M 2026-03
Bristol-Myers Squibb USD 18.66B 499M 2026-06
Eli Lilly USD 36.63B 1.41B 2026-03
GlaxoSmithKline GBP 21.53B 895M 2026-06
Merck USD 26.94B 1.38B 2026-03
Novartis USD 31.75B 374M 2026-06
Novo Nordisk DKK 225.16B 9.5B 2026-03
Novo Nordisk DKK 32.79B 203.33B 2025-06
Pacira USD 108.79M 11.8M 2026-03
Sanofi EUR 31.93B 1.92B 2026-06
Supernus Pharmaceuticals USD 373.93M 35.76M 2026-03